ℹ️
🇬🇧
Search
Search for people relevant for "β-blockers"
β-blockers
Person
Class
Person
Publication
Programmes
prof. MUDr. Petr Arenberger DrSc., MBA
Academic staff at Third Faculty of Medicine
16 classes
227 publications
Classes
class
Student Research Activity
C4SVA110 |
Third Faculty of Medicine
class
Dermatovenerology
+3
C5VL004 |
Third Faculty of Medicine
class
Atopic dermatitis
+1
CCOC6909 |
Third Faculty of Medicine
class
Dermatology and Diseases of the Mucosa
+2
CDH003P2 |
Third Faculty of Medicine
class
ERASMUS - Dermatovenerology
CERA5P0076 |
Third Faculty of Medicine
class
IIC - 10. Cutaneous Changes
CMCP1034 |
Third Faculty of Medicine
class
IIB - Dermatovenerology
CMPRKL23 |
Third Faculty of Medicine
class
Nursing Care in Dermatovenerology
+2
CNS012P2 |
Third Faculty of Medicine
Load more classes (6)
Publications
publication
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic
2024 |
Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report
2023 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic
2023 |
Third Faculty of Medicine, First Faculty of Medicine
publication
Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238
2023 |
Third Faculty of Medicine
publication
Malignant melanoma: diagnosis and treatment based on current guidelines
2023 |
Third Faculty of Medicine
publication
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
2023 |
Third Faculty of Medicine
publication
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
2023 |
Central Library of Charles University
publication
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023
2023 |
Third Faculty of Medicine
publication
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023
2023 |
Third Faculty of Medicine
publication
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023
2023 |
Third Faculty of Medicine
Load more publications (217)
Loading network view...